Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-o

Japanese insulin-naive patients without complications, on BOT with glargine, show higher chances of attaining HbA1c < 7.0% than those with complications.